Advertisement

Imaging of Benign Prostatic Conditions

  • E. Justin Martinez
  • Hong Truong
  • Soroush Rais-BahramiEmail author
Chapter

Abstract

Benign diseases of the prostate include a spectrum of pathologies that are caused by congenital development such as prostatic cysts, aging such as benign prostatic hyperplasia, and infections such as bacterial prostatitis and prostatic abscess. Imaging of non-malignant conditions of the prostate can be performed using different imaging modalities. The utilities of prostate imaging include detection and follow up of prostate abnormalities, investigation of symptoms that can be caused by diseases of the prostate, selection of treatment options, and image guidance for surgical intervention. In this chapter, we will discuss the presentations, etiologies, and diagnoses of benign prostatic hyperplasia, prostatitis, prostatic abscess, prostatic cysts, and prostatic calculi. While transrectal ultrasonography is the standard imaging modality of the majority of prostatic conditions, advancement in computed tomography (CT) and magnetic resonance imaging (MRI), especially for investigation of prostate cancer, have led to increased incidental findings of asymptomatic benign prostatic pathologies and better delineation of these diseases.

Keywords

Benign prostatic hyperplasia Prostatitis Prostatic abscess Transrectal ultrasound Imaging of benign prostatic conditions Prostate imaging 

References

  1. 1.
    McNeal J. Pathology of benign prostatic hyperplasia. insight into etiology. Urol Clin North Am. 1990;17(3):477–86.PubMedGoogle Scholar
  2. 2.
    Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474–9.PubMedGoogle Scholar
  3. 3.
    Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in america project: benign prostatic hyperplasia. J Urol. 2005;173(4):1256–61. doi: S0022-5347(05)61064-6 [pii].CrossRefPubMedGoogle Scholar
  4. 4.
    Kolman C, Girman CJ, Jacobsen SJ, Lieber MM. Distribution of post-void residual urine volume in randomly selected men. J Urol. 1999;161(1):122–7.CrossRefPubMedGoogle Scholar
  5. 5.
    McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793–803.CrossRefPubMedGoogle Scholar
  6. 6.
    Emberton M, Cornel EB, Bassi PF, Fourcade RO, Gomez JM, Castro R. Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management. Int J Clin Pract. 2008;62(7):1076–86.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol. 2004;46(5):547–54.CrossRefPubMedGoogle Scholar
  8. 8.
    Chia SJ, Heng CT, Chan SP, Foo KT. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int. 2003;91(4):371–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Nose H, Foo KT, Lim KB, Yokoyama T, Ozawa H, Kumon H. Accuracy of two noninvasive methods of diagnosing bladder outlet obstruction using ultrasonography: intravesical prostatic protrusion and velocity-flow video urodynamics. Urology. 2005;65(3):493–7. doi: S0090-4295(04)01211-7 [pii].CrossRefPubMedGoogle Scholar
  10. 10.
    Keqin Z, Zhishun X, Jing Z, Haixin W, Dongqing Z, Benkang S. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement. Urology. 2007;70(6):1096–9. doi: S0090-4295(07)01972-3 [pii].CrossRefPubMedGoogle Scholar
  11. 11.
    Stravodimos KG, Petrolekas A, Kapetanakis T, et al. TRUS versus transabdominal ultrasound as a predictor of enucleated adenoma weight in patients with BPH: a tool for standard preoperative work-up? Int Urol Nephrol. 2009;41(4):767–71. doi: 10.1007/s11255-009-9554-9.CrossRefPubMedGoogle Scholar
  12. 12.
    Watanabe H, Kato H, Kato T, Morita M, Tanaka M. Diagnostic application of ultrasonotomography to the prostate. Nihon Hinyokika Gakkai Zasshi. 1968;59(4):273–9.PubMedGoogle Scholar
  13. 13.
    Zlotta AR, Djavan B, Damoun M, et al. The importance of measuring the prostatic transition zone: an anatomical and radiological study. BJU Int. 1999;84(6):661–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Tokgoz O, Tokgoz H, Unal I, et al. Diagnostic values of detrusor wall thickness, postvoid residual urine, and prostate volume to evaluate lower urinary tract symptoms in men. Diagn Interv Radiol. 2012;18(3):277–81.PubMedGoogle Scholar
  15. 15.
    Matthews GJ, Motta J, Fracchia J. The accuracy of transrectal ultrasound prostate volume estimation: clinical correlations. J Clin Ultrasound. 1996;24(9):501–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Tewari A, Indudhara R, Shinohara K, et al. Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia. J Clin Ultrasound. 1996;24(4):169–74.CrossRefPubMedGoogle Scholar
  17. 17.
    Hricak H, Dooms GC, McNeal JE, et al. MR imaging of the prostate gland: normal anatomy. AJR Am J Roentgenol. 1987;148(1):51–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Sommer FG, McNeal JE, Carrol CL. MR depiction of zonal anatomy of the prostate at 1.5 T. J Comput Assist Tomogr. 1986;10(6):983–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Turkbey B, Fotin SV, Huang RJ, et al. Fully automated prostate segmentation on MRI: comparison with manual segmentation methods and specimen volumes. AJR Am J Roentgenol. 2013;201(5):W720–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Hoffelt CS, Marshall LM, Garzotto M, et al. A comparison of CT scan to transrectal ultrasound-mesaured prostate volume in untreated prostate cancer. Int J Radiat Oncol Biol Phys. 2003;57:29–32.CrossRefPubMedGoogle Scholar
  21. 21.
    Badiozamani KR, Wallner K, Cavanagh W, et al. Comparability of CT-based and TRUS-based prostate volumes. Int J Radiat Oncol Biol Phys. 1999;43:375–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Fiorino C, Reni M, Michalski J, et al. Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. Radiother Oncol. 1998;47:285–92.CrossRefPubMedGoogle Scholar
  23. 23.
    The national kidney and urologic diseases advisory board 1990 long-range plan: window on the 21st century. J Urol. 1991;145(3):568–93.Google Scholar
  24. 24.
    Collins MM, Stafford RS, O’Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. 1998;159(4):1224–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Kong do H, Yun CJ, Park HJ, Park NC. The efficacy of mirodenafil for chronic prostatitis/chronic pelvic pain syndrome in middle-aged males. Department of Urology, Pusan National University School of Medicine, Busan, Korea. pISSN: 2287–4208/eISSN: 2287–4690. World J Mens Health. 2014;32(3):145–50.Google Scholar
  26. 26.
    Krieger JN, Nyberg Jr L, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Horcajada JP, Vilana R, Moreno-Martínez A, Alvarez-Vijande R, Bru C, Bargalló X, Buñesch L, José Antonio M, Josep M. Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications. Scand J Infect Dis. 2003;35(2):114–20.CrossRefPubMedGoogle Scholar
  28. 28.
    Doble A, Carter SS. Ultrasonographic findings in prostatitis. St. Mary’s hospital, London, England. Urol Clin North Am. 1989;16(4):763–72.PubMedGoogle Scholar
  29. 29.
    Ludwig M, Weidner W, Schroeder-Printzen I, Zimmermann O, Ringert RH. Transrectal prostatic sonography as a useful diagnostic means for patients with chronic prostatitis or prostatodynia. Br J Urol. 1994;73(6):664–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Palmas AS, Coelho MF, Fonseca JF. Color Doppler ultrasonographic scanning in acute bacterial prostatitis. Arch Ital Urol Androl. 2010;82(4):271–4.PubMedGoogle Scholar
  31. 31.
    Logan JK, Walton-Diaz A, Rais-Bahrami S, et al. Changes observed in multiparametric prostate magnetic resonance imaging characteristics correlate with histopathological development of chronic granulomatous prostatitis afer intravesicle bacillus Calmette-Guerin therapy. J Comput Assist Tomogr. 2014;38:274–6.PubMedCentralCrossRefPubMedGoogle Scholar
  32. 32.
    Nagel K, Schouten M, Hambrock T, Litjens G, Hoeks C, Haken B, Fütterer J. Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T. Radiology. 2013;267:164–72.CrossRefPubMedGoogle Scholar
  33. 33.
    Granados EA, Riley G, Salvados J, Vicente J. Prostatic abscess: diagnosis and treatment. J Urol. 1992;148:80–2.PubMedGoogle Scholar
  34. 34.
    Oliveira P, Andrade JA, Porto HC, Filho JE, Vinhes AF. Diagnosis and treatment of prostatic abscess. Int Braz J Urol. 2003;29(1):30–4.CrossRefPubMedGoogle Scholar
  35. 35.
    Thornhill BA, Morehouse HT, Coleman P, Hoffman-Tretin JC. Prostatic abscess: CT and sonographic findings. AJR Am J Roentgenol. 1987;148:899–900.CrossRefPubMedGoogle Scholar
  36. 36.
    Papanicolaou N, Pfister RC, Stafford SA, Parkhurst EC. Prostatic abscess: imaging with transrectalsonography and MR. AJR Am J Roentgenol. 1987;149:981–2.CrossRefPubMedGoogle Scholar
  37. 37.
    Galosi AB, Montironi R, Fabiani A, Lacetera V, Galle G, Muzzonigro G. Cystic lesions of the prostate gland: an ultrasound classification with pathological correlation. J Urol. 2009;181:647–57.CrossRefPubMedGoogle Scholar
  38. 38.
    Coppens L, Bonnet P, Andrianne R, de Leval J. Adult müllerian duct or utricle cyst: clinical significance and therapeutic management of 65 cases. J Urol. 2002;167(4):1740–4.CrossRefPubMedGoogle Scholar
  39. 39.
    Halpern EJ, Hirsch IH. Sonographically guided transurethral laser incision of a müllerian duct cyst for treatment of ejaculatory duct obstruction. AJR Am J Roentgenol. 2000;175:777–8. 0361–803X/00/1753–777.CrossRefPubMedGoogle Scholar
  40. 40.
    Nghiem HT, Kellman GM, Sandberg SA, Craig BM. Cystic lesions of the prostate. Radiographics. 1990;10:635–50.CrossRefPubMedGoogle Scholar
  41. 41.
    McDermott VG, Meakem III TJ, Stolpen AH, Schnall MD. Prostatic and periprostatic cysts: findings on MR imaging. Am J Roentgenol. 1995;164:123–7.CrossRefGoogle Scholar
  42. 42.
    Grayhack JT, McVary KT, Kozlowski JM. Benign prostatic hyperplasia. In: Gillenwater JY, Grayhack JT, Howards SS, Mitchell ME, editors. Adults and pediatrics urology, vol. 2. 4th ed. St. Louis: Mosby; 2002. p. 1401–70.Google Scholar
  43. 43.
    Søndergaard G, Vetner M, Christensen PO. Prostatic calculi. Acta Pathol Microbiol Immunol Scand A. 1987;95(3):141–5.PubMedGoogle Scholar
  44. 44.
    Venyo A. Prostatic calculi: a review of the literature. WebmedCentral Urol. 2012;3(6):WMC003463.Google Scholar
  45. 45.
    Shoskes DA, Thomas KD, Gomez E. Anti-nonbacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol. 2005;173(2):474–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • E. Justin Martinez
    • 1
  • Hong Truong
    • 2
  • Soroush Rais-Bahrami
    • 3
    Email author
  1. 1.Department of UrologyUniversity of Alabama at BirminghamBirminghamUSA
  2. 2.Department of UrologyKimmel Cancer Center, Thomas Jefferson UniversityPhiladelphiaUSA
  3. 3.Departments of Urology and RadiologyUniversity of Alabama at BirminghamBirminghamUSA

Personalised recommendations